Charles Schwab’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28B | Buy |
|
|||||
|
2025
Q1 | $3.7B | Buy |
|
|||||
|
2024
Q4 | $3.41B | Sell |
|
|||||
|
2024
Q3 | $3.16B | Buy |
|
|||||
|
2024
Q2 | $2.45B | Buy |
|
|||||
|
2024
Q1 | $2.91B | Buy |
|
|||||
|
2023
Q4 | $583M | Buy |
|
|||||
|
2023
Q3 | $652M | Buy |
|
|||||
|
2023
Q2 | $718M | Sell |
|
|||||
|
2023
Q1 | $787M | Buy |
|
|||||
|
2022
Q4 | $806M | Buy |
|
|||||
|
2022
Q3 | $792M | Buy |
|
|||||
|
2022
Q2 | $834M | Sell |
|
|||||
|
2022
Q1 | $804M | Buy |
|
|||||
|
2021
Q4 | $674M | Buy |
|
|||||
|
2021
Q3 | $632M | Buy |
|
|||||
|
2021
Q2 | $692M | Buy |
|
|||||
|
2021
Q1 | $641M | Sell |
|
|||||
|
2020
Q4 | $653M | Buy |
|
|||||
|
2020
Q3 | $633M | Sell |
|
|||||
|
2020
Q2 | $656M | Sell |
|
|||||
|
2020
Q1 | $1.09B | Sell |
|
|||||
|
2019
Q4 | $1.26B | Buy |
|
|||||
|
2019
Q3 | $700M | Buy |
|
|||||
|
2019
Q2 | $609M | Buy |
|
|||||
|
2019
Q1 | $612M | Buy |
|
|||||
|
2018
Q4 | $354M | Buy |
|
|||||
|
2018
Q3 | $406M | Buy |
|
|||||
|
2018
Q2 | $348M | Buy |
|
|||||
|
2018
Q1 | $387M | Buy |
|
|||||
|
2017
Q4 | $360M | Buy |
|
|||||
|
2017
Q3 | $358M | Buy |
|
|||||
|
2017
Q2 | $301M | Buy |
|
|||||
|
2017
Q1 | $279M | Buy |
|
|||||
|
2016
Q4 | $287M | Buy |
|
|||||
|
2016
Q3 | $254M | Buy |
|
|||||
|
2016
Q2 | $340M | Buy |
|
|||||
|
2016
Q1 | $287M | Buy |
|
|||||
|
2015
Q4 | $301M | Buy |
|
|||||
|
2015
Q3 | $250M | Sell |
|
|||||
|
2015
Q2 | $284M | Buy |
|
|||||
|
2015
Q1 | $271M | Buy |
|
|||||
|
2014
Q4 | $237M | Buy |
|
|||||
|
2014
Q3 | $201M | Sell |
|
|||||
|
2014
Q2 | $205M | Buy |
|
|||||
|
2014
Q1 | $207M | Sell |
|
|||||
|
2013
Q4 | $246M | Buy |
|
|||||
|
2013
Q3 | $207M | Buy |
|
|||||
|
2013
Q2 | $180M | Buy |
|